Jump to content

Splenogonadal fusion

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by OAbot (talk | contribs) at 09:38, 14 August 2023 (Open access bot: pmc, doi updated in citation with #oabot.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Splenogonadal fusion
Intra-operative gross photograph of the spleen attached to the left testis in a 1-year old boy with splenogonadal fusion

Splenogonadal fusion is a rare congenital malformation that results from an abnormal connection between the primitive spleen and gonad during gestation. A portion of the splenic tissue then descends with the gonad. Splenogonadal fusion has been classified into two types: continuous, where there remains a connection between the main spleen and gonad; and discontinuous, where ectopic splenic tissue is attached to the gonad, but there is no connection to the orthotopic spleen. Patients can also have an accessory spleen. Patients with continuous splenogonadal fusion frequently have additional congenital abnormalities including limb defects, micrognathia, skull anomalies, Spina bifida, cardiac defects, anorectal abnormalities, and most commonly cryptorchidism.[1] Terminal limb defects have been documented in at least 25 cases which makes up a separate diagnosis of splenogonadal fusion limb defect (SGFLD) syndrome.

The anomaly was first described in 1883 by Bostroem.[2] Since then more than 150 cases of splenogonadal fusion have been documented, predominantly in males.[3] The condition is considered benign.[4] A few cases of testicular neoplasm have been reported in association with splenogonadal fusion.[5][6] The reported cases have occurred in patients with a history of cryptorchidism, which is associated with an elevated risk of neoplasm.[6]

Splenogonadal fusion occurs with a male-to-female ratio of 16:1, and is seen nearly exclusively on the left side.[3] The condition remains a diagnostic challenge, but preoperative consideration of the diagnosis and use of ultrasound may help avoid unnecessary orchiectomy. The presence of splenic tissue may be confirmed with a technetium-99m sulfur colloid scan.[7]

Classification

Left testis in scrotal position with adherent accessory spleen.

Splenogonadal fusion is separated into two types:

  • Continuous (55%): The native spleen is connected to the gonad. The connection occurs through a cord of splenic tissue or fibrous band.
  • Discontinuous (45%): Ectopic splenic tissue is present and attached to the gonad. An accessory spleen is present and the native spleen lacks the direct attachment to the gonad.
Continuous Discontinuous
Frequency 55% 45%
Associated malformations Common Uncommon
Imaging Possible visualization of connecting cord between native spleen and gonad No identifiable link between native spleen and gonad
Technetium-99m Scintigraphy Radioactive tracer uptake in mass equivalent to uptake in normal splenic tissue Radioactive tracer uptake in mass equivalent to uptake in normal splenic tissue

Pathogenesis

The cause of splenogonadal fusion is still unclear, and there are several proposed mechanisms. A developmental field defect that occurs during blastogenesis is the current explanation of pathogenesis. The spleen derives from mesenchymal tissue and an inappropriate fusion can happen between the gonadal ridge during gut rotation, which occurs between weeks 5 and 8 of fetal life.[8] Splenogonadal fusion may result from an unknown teratogenic insult. The timing of this insult may correlate to the severity of associated defects. There is also postulation that fusion may occur due to adhesion after an inflammatory response or a lack of apoptosis between the structures. Siblings documented to have splenogonadal fusion and an accessory spleen provides additional evidence of a possible genetic component.[8]

Associated Conditions

Additional congenital abnormalities are most often found associated with the continuous type of splenogonadal fusion. These abnormalities include micrognathia, macroglossia, anal atresia, and pulmonary hypoplasia.[9] The most commonly associated malformation is cryptorchidism. When limb abnormalities occur, Splenogonadal Fusion with Limb Defects is made as a separate diagnosis. Splenogonadal Fusion with Limb Defects is also of unknown cause but some literature suggests that the condition may be related to Hanhart syndrome and facial femoral syndrome.[9] Splenogonadal fusion has also been identified in infants with Möbius syndrome and Poland syndrome.[10]

Diagnosis

Diagnosis can be challenging pre-operatively, as patients are commonly asymptomatic. Physical examination can aid in diagnosis if the mass is palpated, but further confirmatory tests are necessary. Females are reportedly less affected by splenogonadal fusion, though it is possible that the condition is underdiagnosed due to the difficulty of internal gonad examination in females.[8] On scrotal ultrasound, ectopic splenic tissue may appear as an encapsulated homogeneous extratesticular mass, isoechoic with the normal testis. Subtle hypoechoic nodules may be present in the mass.[7] Limitations of doppler ultrasonography include visualizing the nonspecific paratesticular masses which can mimic malignancies such as rhabdomyosarcoma or embryonal sarcoma.[11] Technetium-99m sulfur colloid scan is sensitive to target the liver, spleen, and bone marrow, therefore the scans can be used to identify ectopic splenic tissue when clinical suspicion is high.[12] When technetium-99m sulfur colloid scans are not included in a patient's diagnostic workup, the diagnosis is often not made until the surgeon performs an abdominal exploration using laparoscopy which can visualize the splenic tissue grossly. Evaluation by biopsy including frozen section procedure is confirmatory for splenogonadal fusion. Histological examination will show normal splenic tissue which is made up of red and white pulp.[13] Many people with splenogonadal fusion go undiagnosed without complication during their lifetime. Many cases have been diagnosed at autopsy or incidentally after orchiectomy.[8]

Treatment

Treatment remains controversial given the benign nature of splenogonadal fusion. Splenogonadal fusion does not have known clinical manifestations that require intervention. Clinical observation is considered when the mass is diagnosed pre-operatively. Surgery is often required to confirm the diagnosis and exclude a mimic of a malignant mass. Surgical approach should attempt to divide the mass and the gonad at the connecting plane for removal of the splenic tissue. Orchiectomy is generally not indicated. Causality between splenogonadal fusion and future malignant transformation has not been established, but literature has highlighted infrequent cases of testicular neoplasms and splenogonadal fusion. These cases were found in patients who also had a history of cryptorchidism, which is a known risk factor for testicular cancer.[14]

See also

References

  1. ^ Kocher, NJ; Tomaszewski, JJ; Parsons, RB; Cronson, BR; Altman, H; Kutikov, A (Jan 2014). "Splenogonadal fusion: a rare etiology of solid testicular mass". Urology. 83 (1): e1-2. doi:10.1016/j.urology.2013.09.019. PMID 24200197.
  2. ^ Khairat, AB; Ismail, AM (Aug 2005). "Splenogonadal fusion: case presentation and literature review". Journal of Pediatric Surgery. 40 (8): 1357–60. doi:10.1016/j.jpedsurg.2005.05.027. PMID 16080949.
  3. ^ a b Varma, DR; Sirineni, GR; Rao, MV; Pottala, KM; Mallipudi, BV (Sep 2007). "Sonographic and CT features of splenogonadal fusion". Pediatric Radiology. 37 (9): 916–9. doi:10.1007/s00247-007-0526-x. PMID 17581747. S2CID 27596524.
  4. ^ Lin, CS; Lazarowicz, JL; Allan, RW; Maclennan, GT (Jul 2010). "Splenogonadal fusion". The Journal of Urology. 184 (1): 332–3. doi:10.1016/j.juro.2010.04.013. PMID 20488470.
  5. ^ Imperial, SL; Sidhu, JS (Oct 2002). "Nonseminomatous germ cell tumor arising in splenogonadal fusion". Archives of Pathology & Laboratory Medicine. 126 (10): 1222–5. doi:10.5858/2002-126-1222-NGCTAI. PMID 12296764.
  6. ^ a b Lopes RI, de Medeiros MT, Arap MA, Cocuzza M, Srougi M, Hallak J (Jan–Mar 2012). "Splenogonadal fusion and testicular cancer: case report and review of the literature". Einstein (Sao Paulo, Brazil). 10 (1): 92–5. doi:10.1590/s1679-45082012000100019. PMID 23045834.
  7. ^ a b Guarin, U; Dimitrieva, Z; Ashley, SJ (Oct 1975). "Splenogonadal fusion-a rare congenital anomaly demonstrated by 99Tc-sulfur colloid imaging: case report". Journal of Nuclear Medicine. 16 (10): 922–4. PMID 240914.
  8. ^ a b c d Chiaramonte, C; Siracusa, F; Li Voti, G (March 2014). "Splenogonadal Fusion: A Genetic Disorder?-Report of a Case and Review of the Literature". Urology Case Reports. 2 (2): 67–9. doi:10.1016/j.eucr.2014.01.003. PMC 4733014. PMID 26952691.
  9. ^ a b McPherson, F; Frias, JL; Spicer, D; Opitz, JM; Gilbert-Barness, EF (1 August 2003). "Splenogonadal fusion-limb defect "syndrome" and associated malformations". American Journal of Medical Genetics. Part A. 120A (4): 518–22. doi:10.1002/ajmg.a.10728. PMID 12884431. S2CID 40127231.
  10. ^ Cabrera Viteri, MI; Acosta Farina, D; Morales Mayorga, H; Cabrera Johnson, M; Albán Castro, S (1 October 2021). "Splenogonadal fusion associated with Moebius and Poland syndromes: first case reported". Cirugia Pediatrica. 34 (4): 219–222. PMID 34606704.
  11. ^ Akbar, SA; Sayyed, TA; Jafri, SZ; Hasteh, F; Neill, JS (November 2003). "Multimodality imaging of paratesticular neoplasms and their rare mimics". Radiographics. 23 (6): 1461–76. doi:10.1148/rg.236025174. PMID 14615558.
  12. ^ Daghas, FA; Asiri, JA; Hassine, H; Ibrahim Aamry, A (March 2022). "99mTc-Sulfur Colloid SPECT/CT in Diagnosis of Splenogonadal Fusion". Journal of Nuclear Medicine Technology. 50 (1): 75–77. doi:10.2967/jnmt.121.262233. PMID 34750231. S2CID 243862063.
  13. ^ Fadel, MG; Walters, U; Smith, A; Bedi, N; Davies, C; Brock, C; Dinneen, M (19 March 2021). "Splenogonadal fusion: aiding detection and avoiding radical orchidectomy". Annals of the Royal College of Surgeons of England. 104 (2): e32–e34. doi:10.1308/rcsann.2021.0080. PMC 10335196. PMID 33739169. S2CID 232298023.
  14. ^ Kadouri, Y; Carnicelli, D; Sayegh, HE; Benslimane, L; Nouini, Y (2020). "Pathogenesis, Diagnosis, and Management of Splenogonadal Fusion: A Literature Review". Case Reports in Urology. 2020: 8876219. doi:10.1155/2020/8876219. PMC 7568155. PMID 33101755.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Splenogonadal_fusion&oldid=1170314037"